Eeal-world相关论文
Ustekinumab:“Real-world”outcomes and potential predictors of nonresponse in treatment-refractory Cro
BACKGROUND Ustekinumab was approved in Europe for the treatment of adults with moderate to severe Crohn's disease(CD......
